HIV Therapeutics Market by Type (Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues, Non-nucleoside reverse transcriptase inhibitors, Protease inhibitors, Integrase [strand transfer] inhibitors, CCR5 inhibitors, Fusion inhibitors), Application (HIV Type-1&2)- and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

HIV Therapeutics Market by Type (Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues, Non-nucleoside reverse transcriptase inhibitors, Protease inhibitors, Integrase [strand transfer] inhibitors, CCR5 inhibitors, Fusion inhibitors), Application (HIV Type-1&2)- and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 2073 | Pages: 175 | May 2017 | Region: Global


Global HIV Therapeutics Market was worth USD 13.2 billion in 2016 and estimated to be growing at a CAGR of 1.4%, to reach USD 14.2 billion by 2021. The human immunodeficiency Virus (HIV) infection refers to a kind of retrovirus that causes (AIDS). HIV affects some immune cells and it weakens immune system bringing about loss of capacity to fight against the organisms that causes diseases.

HIV spreads through exchange of fluids with some infected individual, for example, blood exchange or imparting needles to somebody who is HIV infected. Additionally, HIV can spread from infected mother to child during pregnancy. Here are some of the symptoms of HIV disease are slight fever, weakness, swollen glands, cerebral pains and muscle hurts. Integrase inhibitors section is expected to be the rapid growing class of antiretroviral medications owing to the normal dispatch of extra integrase inhibitors by major players, for example, Gilead Sciences, In., Merck and Co., Inc.

Increasing number of HIV affected cases, innovative advancement in HIV diagnosis and therapeutics, ascend in research exercises for developing HIV immunizations and not aware about the methods of transmission of the infection are driving the worldwide market for HIV therapeutics. Moreover, increase awareness about the accessibility of HIV therapeutics in the market and cost effective sedate treatments for HIV are driving the worldwide HIV therapeutics market. However, different variables, for example, disappointment of treatment sometimes, absence of gifted experts and presentation of non-specific medications in the market are major restraints the HIV therapeutics market.

The HIV Therapeutics Market is broadly categorized into Type (Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues, Non-nucleoside reverse transcriptase inhibitors, Protease inhibitors, Integrase [strand transfer] inhibitors, CCR5 inhibitors, Fusion inhibitors). And on the basis of Application (HIV Type-1&2). On the basis of geography, the global market is analyzed under various regions namely North America, Europe, Asia-Pacific, Middle east and Africa, Latin America. North America, trailed by Europe, has the highest market share for HIV therapeutics because of affordability and availability of costly treatment for HIV infections and developments in medication treatments in this region. Asia is expected to show high development rate in the HIV therapeutics market in next couple of years because of increasing number of HIV affected people and expanding research exercises for creating HIV medications and immunizations in the region.

Some of the major companies dominating the market, by their products and services include GlaxoSmithKline, Bristol-Myers Squibb, Pfizer and Boehringer Ingelheim. Other organizations having huge presence in HIV therapeutics market are Merck, Hoffmann-La Roche and Gilead Sciences.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug Class                   

                                5.1.1 Introduction           

                                5.1.2 integrase inhibitor               

                                5.1.3 nucleoside/nucleotide reverse transcriptase inhibitor         

                                5.1.4  non-nucleoside turn around transcriptase inhibitor             

                                5.1.5 HIV-1 protease inhibitor    

                                5.1.6 pharmacokinetic enhancer              

                                5.1.7 passage inhibitor  

                                5.1.8  Y-o-Y Growth Analysis, Drug class                

                                5.1.9  Market Attractiveness Analysis, Drug class              

                                5.1.10  Market Share Analysis, Drug class              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 HIV Type-1              

                                5.2.3 HIV Type-2              

                                5.2.4 Y-o-Y Growth Analysis, Application               

                                5.2.5 Market Attractiveness Analysis, Application             

                                5.2.6 Market Share Analysis, Application              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 Drug Class

                                                6.1.3.3 HIV TYPE 1&2

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 Drug Class

                                                6.1.4.3 HIV TYPE 1&2

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 Drug Class

                                                6.1.5.3 HIV TYPE 1&2

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Athersys                      

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 StemCells                    

                8.3 Cryo Cell International                           

                8.4 Geron Corporation                  

                8.5 Mesoblast                   

                8.6 Aastrom Biosciences                              

                8.7 Celgene Corporation                              

                8.8 Invitrogen                   

                8.9 Cytori Therapeutics                 

                8.10 Retractable Technologies                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global HIV Therapeutics Market By Region, From 2016-2021 ( USD Million )
  2. Global HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  3. Global Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues Market By Region, From 2016-2021 ( USD Million )
  4. Global Non-nucleoside reverse transcriptase inhibitors Market By Region, From 2016-2021 ( USD Million )
  5. Global Protease inhibitors Market By Region, From 2016-2021 ( USD Million )
  6. Global Integrate [strand transfer] inhibitors Market By Region, From 2016-2021 ( USD Million )
  7. Global Fusion inhibitors Market By Region, From 2016-2021 ( USD Million )
  8. Global HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  9. Global HIV Type 1 Market By Region, From 2016-2021 ( USD Million )
  10. Global HIV Type 2 Market By Region, From 2016-2021 ( USD Million )
  11. North America HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  12. North America Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues Market By Region, From 2016-2021 ( USD Million )
  13. North America Non-nucleoside reverse transcriptase inhibitors Market By Region, From 2016-2021 ( USD Million )
  14. North America Protease inhibitors Market By Region, From 2016-2021 ( USD Million )
  15. North America Integrate [strand transfer] inhibitors Market By Region, From 2016-2021 ( USD Million )
  16. North America Fusion inhibitors Market By Region, From 2016-2021 ( USD Million )
  17. North America HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  18. North America HIV Type 1 Market By Region, From 2016-2021 ( USD Million )
  19. North America HIV Type 2 Market By Region, From 2016-2021 ( USD Million )
  20. United States HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  21. United States HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  22. Canada HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  23. Canada HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  24. Europe HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  25. Europe Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues Market By Region, From 2016-2021 ( USD Million )
  26. Europe Non-nucleoside reverse transcriptase inhibitors Market By Region, From 2016-2021 ( USD Million )
  27. Europe Protease inhibitors Market By Region, From 2016-2021 ( USD Million )
  28. Europe Integrate [strand transfer] inhibitors Market By Region, From 2016-2021 ( USD Million )
  29. Europe Fusion inhibitors Market By Region, From 2016-2021 ( USD Million )
  30. Europe HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  31. Europe HIV Type 1 Market By Region, From 2016-2021 ( USD Million )
  32. Europe HIV Type 2 Market By Region, From 2016-2021 ( USD Million )
  33. U.K. HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  34. U.K. HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  35. Germany HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  36. Germany HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  37. France HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  38. France HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  39. Italy HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  40. Italy HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  41. Spain HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  42. Spain HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  43. Asia-Pacific HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  44. Asia-Pacific Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues Market By Region, From 2016-2021 ( USD Million )
  45. Asia-Pacific Non-nucleoside reverse transcriptase inhibitors Market By Region, From 2016-2021 ( USD Million )
  46. Asia-Pacific Protease inhibitors Market By Region, From 2016-2021 ( USD Million )
  47. Asia-Pacific Integrate [strand transfer] inhibitors Market By Region, From 2016-2021 ( USD Million )
  48. Asia-Pacific Fusion inhibitors Market By Region, From 2016-2021 ( USD Million )
  49. Asia-Pacific HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  50. Asia-Pacific HIV Type 1 Market By Region, From 2016-2021 ( USD Million )
  51. Asia-Pacific HIV Type 2 Market By Region, From 2016-2021 ( USD Million )
  52. Japan HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  53. Japan HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  54. China HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  55. China HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  56. India HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  57. India HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  58. Australia HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  59. Australia HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  60. South Korea HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  61. South Korea HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  62. Latin America HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  63. Latin America Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues Market By Region, From 2016-2021 ( USD Million )
  64. Latin America Non-nucleoside reverse transcriptase inhibitors Market By Region, From 2016-2021 ( USD Million )
  65. Latin America Protease inhibitors Market By Region, From 2016-2021 ( USD Million )
  66. Latin America Integrate [strand transfer] inhibitors Market By Region, From 2016-2021 ( USD Million )
  67. Latin America Fusion inhibitors Market By Region, From 2016-2021 ( USD Million )
  68. Latin America HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  69. Latin America HIV Type 1 Market By Region, From 2016-2021 ( USD Million )
  70. Latin America HIV Type 2 Market By Region, From 2016-2021 ( USD Million )
  71. Brazil HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  72. Brazil HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  73. Argentina HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  74. Argentina HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  75. Mexico HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  76. Mexico HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  77. Rest of Latin America HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  78. Rest of Latin America HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  79. Middle East & Africa HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  80. Middle East & Africa Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues Market By Region, From 2016-2021 ( USD Million )
  81. Middle East & Africa Non-nucleoside reverse transcriptase inhibitors Market By Region, From 2016-2021 ( USD Million )
  82. Middle East & Africa Protease inhibitors Market By Region, From 2016-2021 ( USD Million )
  83. Middle East & Africa Integrate [strand transfer] inhibitors Market By Region, From 2016-2021 ( USD Million )
  84. Middle East & Africa Fusion inhibitors Market By Region, From 2016-2021 ( USD Million )
  85. Middle East & Africa HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  86. Middle East & Africa HIV Type 1 Market By Region, From 2016-2021 ( USD Million )
  87. Middle East & Africa HIV Type 2 Market By Region, From 2016-2021 ( USD Million )
  88. Middle East HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  89. Middle East HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
  90. Africa HIV Therapeutics Market By Type, From 2016-2021 ( USD Million )
  91. Africa HIV Therapeutics Market By Application, From 2016-2021 ( USD Million )
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...
Middle East and Africa Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Ret...
Latin America Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharm...
Asia Pacific Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharma...
Europe Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by end user (Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies....
North America Market Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user (Hospital, Oncology centers, Hospital Pharmacies and Reta...
Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.) and by...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.